SC28 Adverse event development in people with HIV on long-acting Cabotegravir + rilpivirine: timing and clinical insights
Gaia Cologgi, Antonio Di Biagio, Eleonora Sarchi(Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo), G Madeddu, Leonardo Calza(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Giancarlo Orofino(Ospedale Amedeo di Savoia), E Ricci, Filippo Lagi(Policlinico Umberto I), Stefano Rusconi(University of Milan), Emanuele Pontali(Ente Ospedaliero Ospedali Galliera), P Bonfanti(University of Milano-Bicocca), Luigi Pusterla, B Menzaghi(Ospedale di Circolo di Busto Arsizio), E Salomoni(University of Sassari), Marco Franzetti, Salvatore Martini(University of Campania "Luigi Vanvitelli"), L Taramasso, Olivia Bargiacchi(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Giovanni Cenderello(Ospedale di Sanremo), GF Pellicanò, Sergio Ferrara(University of Turin), Teresa Bini(Ospedale San Paolo), MA Carleo, Katia Falasca(University of Chieti-Pescara)
Cited by 0
Related Papers
Hospital-Acquired Infections in Critically Ill Patients With COVID-19
|CHEST Journal|2021|404
MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network
|International Journal of Infectious Diseases|2020|226
The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65 – 74 years and more than 75 years
|BMC Geriatrics|2018|179
Cardiovascular risk and dyslipidemia among persons living with HIV: a review
|BMC Infectious Diseases|2017|152